BioCeuticals UltraBiotic IBS 30c

Description

UltraBiotic IBS contains an evidence-based, dairy-free blend of four probiotic strains known as LAB4 to support the health of the digestive system and may provide relief of symptoms associated with medically diagnosed IBS. It is shelf-stable, providing 25 billion CFU at room temperature and 45 billion CFU when refrigerated.

The LAB4 formulation has been clinically demonstrated to improve the quality of life of people with medically diagnosed irritable bowel syndrome (IBS). Additionally, UltraBiotic IBS may assist with the maintenance of normal healthy intestinal flora during and following antibiotic use, and may also provide nutritional support for normal healthy immune function.

Features:

• An evidence-based blend of Lactobacillus acidophilus (CUL 21 and CUL 60), Bifidobacterium bifidum (CUL 20) and B. animalis ssp. lactis (CUL 34) known as LAB4, which may help promote the maintenance of healthy intestinal flora.
• Clinically demonstrated for symptomatic relief of medically diagnosed IBS; i.e. reducing the number of days of abdominal pain.
• May assist with the maintenance of normal healthy intestinal flora during and following antibiotic therapy.
• May provide nutritional support for normal healthy immune function.
• Contains probiotic strains that have been selected based on their hardiness; the combination has been shown to tolerate a broad variance in temperature.
• Each capsule provides 25 billion CFU when kept at room temperature or 45 billion CFU when refrigerated (2-8°C). Do not freeze.
• Dairy-free and vegetarian friendly.

 

Each vegetarian capsule contains:
Lactobacillus acidophilus (CUL 21 + CUL 60)	30 billion CFU
Bifidobacterium bifidum (CUL 20)	750 million CFU
Bifidobacterium animalis ssp. lactis (CUL 34)	14.25 billion CFU

 

CFU = Colony Forming Units.

No added dairy, gluten, shellfish, soy protein, yeast.

Pregnancy friendly.

Vegan and vegetarian friendly.

• If symptoms persist consult your healthcare practitioner.
• Always read label. Use only as directed.

Prescribing Information:

• If diarrhoea persists for more than 6 hours in infants under 6 months, 12 hours in children under 3 years, 24 hours in children aged 3-6 years or 48 hours in adults and children over 6 years, seek medical advice.
• Mild, temporary gastrointestinal disturbances, such as increased flatulence, may occur with amounts exceeding one billion live organisms. If this occurs reduce the dose, then gradually increase it over time.
• It is recommended to take probiotics at least four hours away from antibiotics to limit a potential reduction in probiotic effectiveness.